Keros Therapeutics
KROS • NASDAQ
Keros Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jasbir S. Seehra, with a market cap of $246.3M.
Market Cap$246.3M
Employees141.0
CEOJasbir S. Seehra
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Keros Therapeutics FAQ
Common questions about Keros Therapeutics
Keros Therapeutics is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $2.6M.
Keros Therapeutics has approximately 141 employees.